Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by GAWORSKI, C. L.
Right arrow Articles by ABDO, K. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by GAWORSKI, C. L.
Right arrow Articles by ABDO, K. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 Oxford University Press

research-article

Prechronic Inhalation Toxicity Studies of Isobutyl Nitrite1

C. L. GAWORSKI*,2, C. ARANYI*,3, A. HALL, III{dagger}, B. S. LIVINE{ddagger}, C. D. JACKSON§ and K. M. ABDO

*IIT Research Institute 10 West 35th Street, Chicago, Illinois 60616 {dagger}Pathology Associates, Inc. Chicago, Illinois 60616 {ddagger}University of Illinois at Chicago Chicago, illinois 60612 §National Center for Toxicological Research Jefferson Arkansas 72079 National institute of Environmental Health Sciences, National Toxicology Program Research Triangle Park, North Carolina 27709

Received September 23, 1991; accepted February 17, 1992

Isobutyl nitrite (IBN) is a volatile liquid that has become increasingly popular as an inhaled recreational drug. To investigate short-term toxic effects and establish exposure parameters for chronic inhalation studies, F344/N rats and B6C3F1 mice were exposed to IBN vapors on a 6 hr/day + t90, 5 days/week schedule. Twelve exposures were administered at concentrations of 0, 100, 200, 400, 600, and 800 ppm IBN. This exposure series resulted mortality in rats exposed to ≥600 ppm and mice exposed to 800 ppm. Animals exposed at the lower concentrations developed hyperplasia of the bronchiolar and nasal turbinate epithelium (rats and mice) and lymphocytic atrophy in the spleen and thymus (mice). Longer term, 13-week, subchronic exposures were conducted at concentrations of 0, 10, 25, 75, 150, and 300 ppm IBN. Exposure to 300 ppm IBN reduced the body weight gains in both sexes of rats and in female mice. IBN-related clinical pathology changes included reduced RBC counts accompanied by moderate increases in mean corpuscular volume and reticulocyte counts, increased WBC counts, and mildly increased methemoglobin concentration. Bone marrow hyperplasia was observed in all groups of IBN-exposed rats, while in mice only females at ≥l50 ppm IBN displayed this change. Excessive splenic pulp hematopoiesis was noted in mice at all IBN exposure levels. Respiratory system changes included increased lung weights in rats and female mice at ≥300 ppm, hyperplasia of the nasal mucosa (male rats at ≥75 ppm and female rats at ≥150 ppm), and hyperplasia of the lung epithelium (male mice at ≥150 ppm and female mice at ≥75 ppm). The results suggested that a concentration of 150 ppm could be used as the highest exposure level for subsequent chronic inhalation tests.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.